Criteria for Diagnosis and Molecular Monitoring of NPM1-Mutated AML.

Overview of attention for article published in Blood Cancer Discovery, December 2023

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 17 X posts from 14 X users, with an upper bound of 14,183 followers.

RT @BCD_AACR: Read the review in the latest issue, by Brunangelo Falini and @DillonHaem. Criteria for diagnosis and molecular monitoring of…

Read the latest review in the January issue, by Brunangelo Falini and @DillonHaem. Criteria for diagnosis and molecular monitoring of #NPM1-mutated #AML. https://t.co/UileK6FNpX @UniperugiaNews @kingsmedicine #acutemyeloidleukemia #leusm https://t.co/ZKZP9

RT @BCD_AACR: Read the latest review in the January issue, by Brunangelo Falini and @DillonHaem. Criteria for diagnosis and molecular monit…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 13 additional X posts.